Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity.
about
Regulation of epithelial-mesenchymal transition by tumor-associated macrophages in cancerClinical Significance of SASH1 Expression in GliomaMiR-506 suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinomaAssociation between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.Molecularly Targeted Therapy of Human Hepatocellular Carcinoma Xenografts with Radio-iodinated Anti-VEGFR2 Murine-Human Chimeric FabBRD7 Acts as a Tumor Suppressor Gene in Lung Adenocarcinoma.Prognostic value of FOXQ1 in patients with malignant solid tumors: a meta-analysis.Overexpression of Rab27B is correlated with distant metastasis and poor prognosis in ovarian cancerDecreased expression of IDH1-R132H correlates with poor survival in gastrointestinal cancer.Tumor-associated macrophages induce the expression of FOXQ1 to promote epithelial-mesenchymal transition and metastasis in gastric cancer cells.The relationship between platinum drug resistance and epithelial-mesenchymal transition.High expression levels of Wnt5a and Ror2 in laryngeal squamous cell carcinoma are associated with poor prognosisFOXQ1 regulates senescence-associated inflammation via activation of SIRT1 expressionReversing cancer stemness.FOXM1 and FOXQ1 Are Promising Prognostic Biomarkers and Novel Targets of Tumor-Suppressive miR-342 in Human Colorectal Cancer.The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster.IL-4 driven transcription factor FoxQ1 is expressed by monocytes in atopic dermatitis and stimulates monocyte migration.
P2860
Q26773786-FB6AD0E6-CF48-4B75-B359-906EE32E3D61Q30009095-AEE2F377-22D7-4D98-B109-596B70977343Q35598357-85AF2E46-DBD7-42EA-9372-6AE29E7CB6C7Q35632213-30D45D3B-03F7-4992-BCB4-86E153A9CA70Q35662815-9331EE68-DD6C-4464-9F84-9956A61F2F1AQ36118557-110329F5-F6F1-44A7-82D3-9FBF5CEA4989Q36331298-9FFB0D02-0CF8-4ED9-AB3D-7AD10DBB696BQ37106757-910EAA53-8B8D-451E-8F91-0E3F9BADCB73Q37687447-00A7D6C3-1F44-423B-A213-5D2F4CD3539CQ38632883-92391667-946D-414C-92CB-932B493716FEQ39061847-3874AD81-081F-412D-A825-2516B94B12E9Q41145048-0E00C79B-5D16-40B2-8C0B-68C443E08910Q41335606-789D7224-1CDB-45DD-84F6-F5A7206A43C2Q41583471-4BAB627F-5DAC-4A43-9984-CB262B3784F6Q41637392-F9980C58-5D80-4313-8D36-8C99958A9C99Q42378409-3EF68AA7-1B96-42C6-842B-3A6B198A0BDAQ47116025-CA99215B-93DB-4472-B068-B8E12DC8F118
P2860
Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity.
@en
type
label
Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity.
@en
prefLabel
Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity.
@en
P2093
P2860
P356
P1433
P1476
Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity
@en
P2093
Haiying Wang
Huijun Zhu
Songshi Ni
P2860
P304
P356
10.18632/ONCOTARGET.2103
P407
P577
2014-10-01T00:00:00Z